Dyne Therapeutics, Inc.DYNNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-2.99
Operating CF/Share$-2.65
Free CF/Share$-2.80
Cash/Share$5.58
Book Value/Share$4.88
Tangible Book/Share$4.88
Equity/Share$4.88
Interest Debt/Share$0.87
CapEx/Share$0.15
Dividend/Share$0.00
Valuation
Market Cap$2.89B
Enterprise Value$2.44B
P/E Ratio-5.99P/S Ratio0.00P/OCF Ratio-6.75
P/FCF Ratio-7.29
P/B Ratio3.67P/TB Ratio3.67
EV/Sales0.00EV/EBITDA-5.63
Graham Valuation
Graham Number--
Graham Net-Net$4.35
Profitability
Earnings Yield-16.70%FCF Yield-13.72%ROE-66.17%ROIC-55.30%Return on Tangible Assets-48.88%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-5.67%
CapEx/Revenue0.00%
CapEx/Depreciation8.44
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.17Debt/Assets0.14Debt/Market Cap0.04
Net Debt/EBITDA1.05
Current Ratio13.47Interest Coverage-149.82xIncome Quality0.89Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$691.78M
Working Capital$746.41M
Invested Capital$792.20M
Intangibles/Assets0.00%